INS and type 1 diabetes mellitus: The patient was diagnosed with type 1 diabetes and was treated with insulin degludec in combination with insulin aspartate, and he was discharged on July 19th, 2023 with the hypoglycemic regimen (insulin degludec 5 units in the morning and insulin aspartate 4 units three times a day).